Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

BAX COV BDX BCR SEK Bitcoins Investing Precious Metals Education 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Collecting data for BCR

CR Bard news

 
 Companies |  Insiders  | Dashboard  
  
Add To Portfolio  add BCR to portfolio
   

CR Bard Inc

Stock@New York Stock Exchange 
United States USD
  
18.65 times
    
Use CR Bard Inc news together with your stock portfolios to enhance returns of your portfolios and to determine Stock optimization strategy that fits your criteria.  Suggest Portfolio
View CR Bard Timeline

    
  
One day ago at utahpeoplespost.com         
C.R. Bard Rating Reiterated by JPMorgan Chase
C. R. Bard Inc. is engaged in the design manufacture packaging distribution and sale of medical surgical diagnostic and patient care devices.
Check History
Focus
  
  
Few days ago at www.digitaljournal.com         
C.R. Bard Transvaginal Mesh Lawsuit News Bernstein Liebhard LLP Notes ...
Transvaginal mesh lawsuit claims involving products manufactured by C.R. Bard Inc. continue to move forward in a consolidated litigation underway in New Jersey Atlantic County Superior Court Bernstein Liebhard LLP reports.
Check History
Focus
  
  
Few days ago at www.watchlistnews.com         
CR Bard Overweight Rating Reaffirmed at JPMorgan Chase
C.R. Bard logo C.R. Bard stock had its overweight rating reaffirmed by stock analysts at JPMorgan Chase in a report issued on Thursday Analyst Ratings Network reports. JMP Securities Reiterates Market Outperform Rating for C.R. Bard Zolmax A New High for CR Bard Zacks.com
Check History
Focus
  
  
Few days ago at www.menafn.com         
CR Bard Inc board announces up to USD500m in share repurchase plan
Jun 13 2013 The board of directors of CR Bard Inc BCR a medical technologies company stated on Wednesday that it has authorised the repurchase of up to USD500m of its common stock. C.R. BARD INC. Bard Increases Quarterly Dividend 4traders CR Bard to buyback 500M in common stock MSN Money
Check History
Focus
  
  
Few days ago at utahpeoplespost.com         
C.R. Bard Announces Quarterly Dividend of 0.21
The Utah Peoples Post Jun 13 2013 The company quarterly revenue was up 1.4 on a yearoveryear basis. Analysts expect that C.R. Bard will post 6.26 EPS for the current fiscal year.
Check History
Focus
  
  
Few days ago at money.msn.com         
CR Bard to buyback 500M in common stock
MSN Money Jun 12 2013 In a separate statement the company said it would increase its quarterly dividend by 5 percent to 21 cents per share. The dividend will be payable on Aug. 2 to shareholders of record on July 22.
Check History
Focus
  
  
Few days ago at www.mideasttime.com         
CR Bard Plans Quarterly Dividend of 0.21
Mideast Time Jun 12 2013 C.R. Bard revenue was up 1.4 compared to the same quarter last year. On average analysts predict that C.R. Bard will post 6.26 earnings per share for the current fiscal year.
Check History
Focus
  
  
Few days ago at www.4-traders.com         
C.R. BARD INC. Bard Announces 500 Million Share Repurchase Authorization
4traders Jun 12 2013 The Board of Directors of C. R. Bard Inc. today authorized the repurchase of up to 500 million of the company common stock.
Check History
Focus
  
  
Few days ago at www.4-traders.com         
C.R. BARD INC. Bard Increases Quarterly Dividend
The Board of Directors of C. R. Bard Inc. today increased the quarterly dividend on Bard common stock by 5 percent to 21 cents per share. CR Bard Market Outperform Rating Reaffirmed at JMP Securities Mideast Time CR Bard to buyback 500M in common stock MSN Money
Check History
Focus
  
  
Few days ago at www.sbwire.com         
Recently Released Market Study C. R. Bard Inc. Market Share Analysis
Boston MA 06122013 GlobalData new report quotC. R. Bard Inc. Market Share Analysisquot provides indepth information on C. R. Bard Inc. market position in the different medical equipment markets it operates in. The report provides ...
Check History
Focus
  
  
Few days ago at www.sbwire.com         
quotC. R. Bard Inc. Product Pipeline Analysis 2013 Updatequot Published
Boston MA 06102013 C. R. Bard Inc. is a multinational medical device company. It carries out the design manufacture packaging distribution and sale of medical surgical diagnostic and patient care devices.
Check History
Focus
  
  
Few days ago at empowerednews.net         
NYSEBCR Investor Alert C.R. Bard Inc. under Investigation
The Shareholders Foundation announces that an investigation on behalf of investors of C.R. Bard Inc. shares was initiated over potential securities laws violations by C.R. Bard Inc. and certain of its directors and officers in connection ...
Check History
Focus
  
  
Few days ago at www.watchlistnews.com         
Deutsche Bank Reiterates Hold Rating for CR Bard
C.R. Bard presently has an average rating of Hold and a consensus price target of 105.43. C. R. Bard Inc. is engaged in the design manufacture packaging distribution and sale of medical surgical diagnostic and patient care devices.
Check History
Focus
  
  
Few days ago at harrismartin.com         
C.R. Bard Denied Summary Judgment on FailureToWarn Claims in Pelvic ...
A West Virginia federal judge has denied C.R. Bard Inc. summary judgment on failuretowarn claims brought in a pelvic mesh injury case finding the plaintiffs established an issue of fact as to whether the implanting surgeon was adequately warned of ...
Check History
Focus
  
  
Few days ago at tickerreport.com         
CR Bard Given Market Perform Rating at BMO Capital Markets
C.R. Bard has an average rating of Hold and a consensus price target of 105.43. C. R. Bard Inc. is engaged in the design manufacture packaging distribution and sale of medical surgical diagnostic and patient care devices ...
Check History
Focus
  
    

CR Bard Revenue

CR Bard Inc is rated below average in revenue category among related companies. Market size based on revenue of Medical Instruments and Supplies industry is currently estimated at about 52.21 Billion. CR Bard holds roughly 2.97 Billion in revenue claiming about 6% of all equities under Medical Instruments and Supplies industry.
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog

CR Bard vs. Baxter

Correlation analysis and fundamentals comparison between CR Bard Inc and Baxter International
Correlation
Fundamentals

CR Bard Total Debt

Based on latest financial disclosure CR Bard Inc has Total Debt of 1.41 B. This is 3.63% lower than that of Healthcare sector, and 187.46% higher than that of Medical Instruments and Supplies industry, The Total Debt for all stocks is 73.25% higher than the company.
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
More...
Follow CR Bard News with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
Get Widget
 
Add CR Bard to your reader
Syndicate
 
 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
Take our survey
  
Financial Widget
Financial Widgets
Financial Content
Investing Content
Get Stock Ticker
Stock Tickers
 
Opportunities   Themes   Suggestions
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
  © 2013 Macroaxis Inc. All rights reserved       Custom Reporting   Advertising   Mobile Access   Retirement Grader   Alpha Search   Compare Stocks
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium